Velano Vascular's technologies transform care by potentially reducing the stress and anxiety related to blood draws during hospitalization. The company's technology innovations may reduce pain and discomfort for patients, and aims to enhance safety for providers. Founded by a patient and a physician, Velano Vascular is backed by First Round Capital, Kapor Capital, White Owl Capital, Safeguard Scientifics, The Children's Hospital of Philadelphia (CHOP), Griffin Hospital and dozens of healthcare industry veterans. The company's collaborators include leading U.S. hospital systems and organizations innovating in patient-centered care.
Company Growth (employees)